Cost-utility analysis of 1- and 2-level dorsal lumbar fusions with and without recombinant human bone morphogenic protein-2 at 1-year follow-up

Matthew D. Alvin, Adeeb Derakhshan, Daniel Lubelski, Kalil G. Abdullah, Robert G. Whitmore, Edward C. Benzel, Thomas E. Mroz

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint Dive into the research topics of 'Cost-utility analysis of 1- and 2-level dorsal lumbar fusions with and without recombinant human bone morphogenic protein-2 at 1-year follow-up'. Together they form a unique fingerprint.

Medicine & Life Sciences